- Home
- BCDA vs LOBO Comparison
BCDA vs LOBO Comparison
Compare BCDA & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCDA
- LOBO
- Stock Information
- Founded
- BCDA N/A
- LOBO 2014
- Country
- BCDA United States
- LOBO China
- Employees
- BCDA N/A
- LOBO N/A
- Industry
- BCDA Biotechnology: Pharmaceutical Preparations
- LOBO
- Sector
- BCDA Health Care
- LOBO
- Exchange
- BCDA Nasdaq
- LOBO NYSE
- Market Cap
- BCDA 11.5M
- LOBO 13.6M
- IPO Year
- BCDA N/A
- LOBO 2024
- Fundamental
- Price
- BCDA $2.31
- LOBO $1.50
- Analyst Decision
- BCDA Strong Buy
- LOBO
- Analyst Count
- BCDA 1
- LOBO 0
- Target Price
- BCDA $25.00
- LOBO N/A
- AVG Volume (30 Days)
- BCDA 69.0K
- LOBO 9.5K
- Earning Date
- BCDA 03-26-2025
- LOBO 03-25-2025
- Dividend Yield
- BCDA N/A
- LOBO N/A
- EPS Growth
- BCDA N/A
- LOBO N/A
- EPS
- BCDA N/A
- LOBO 0.00
- Revenue
- BCDA $71,000.00
- LOBO $19,469,766.00
- Revenue This Year
- BCDA N/A
- LOBO $72.16
- Revenue Next Year
- BCDA N/A
- LOBO $41.04
- P/E Ratio
- BCDA N/A
- LOBO $1,391.04
- Revenue Growth
- BCDA N/A
- LOBO N/A
- 52 Week Low
- BCDA $1.63
- LOBO $1.32
- 52 Week High
- BCDA $8.85
- LOBO $4.70
- Technical
- Relative Strength Index (RSI)
- BCDA 45.73
- LOBO N/A
- Support Level
- BCDA $2.27
- LOBO N/A
- Resistance Level
- BCDA $2.95
- LOBO N/A
- Average True Range (ATR)
- BCDA 0.26
- LOBO 0.00
- MACD
- BCDA -0.02
- LOBO 0.00
- Stochastic Oscillator
- BCDA 22.89
- LOBO 0.00
About BCDA BioCardia Inc.
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an "off the shelf" cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.